Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels

COVID-19 is a public health emergency that has rapidly spread to over 200 countries and regions, and no effective treatment has been established to date. Severe and critical cases have been associated with higher mortality due to acute respiratory distress syndrome (ARDS) and cytokine storm. Based o...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Zhen, Liu, Jialin, Shi, Dake, Chen, Wei, Li, Jun, Yan, Ranlin, Bi, Yufang, Hu, Weiguo, Zhu, Zhenggang, Yu, Yingyan, Yang, Zhitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378642/
https://www.ncbi.nlm.nih.gov/pubmed/32760206
http://dx.doi.org/10.7150/ijbs.47652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378642/
https://www.ncbi.nlm.nih.gov/pubmed/32760206
http://dx.doi.org/10.7150/ijbs.47652

Ejemplares similares